Asthma Exacerbations – The Focus For Treatment Of Severe Asthma?
European Respiratory & Pulmonary Diseases · 2015
DOI: 10.17925/erpd.2015.01.01.18 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Respiratory & Pulmonary Diseases, 2015. Verfasst von Therese M Bidder und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Asthma exacerbations (worsening of symptoms requiring oral corticosteroid treatment) impair quality of life, interfere with normal activities and can lead to hospital admission or even death. Predicting and preventing exacerbations is therefore an important focus in asthma management. Good patient education and adherence with appropriate treatment are important, as is detection of when this is not achieved. Increasingly it is recognised that uncontrolled airway inflammation in a risk factor for exacerbation, and detection and control of untreated inflammation can reduce exacerbation rates. As specific biologics are available for asthma treatment it will be important to use biomarkers to select those subgroups that will benefit from each type of treatment.
Zitieren
APA
Bidder, T. M., & Robinson, D. S. (2015). Asthma Exacerbations – The Focus For Treatment Of Severe Asthma?. European Respiratory & Pulmonary Diseases. https://doi.org/10.17925/erpd.2015.01.01.18
Vancouver
Bidder TM, Robinson DS. Asthma Exacerbations – The Focus For Treatment Of Severe Asthma?. European Respiratory & Pulmonary Diseases. 2015. doi:10.17925/erpd.2015.01.01.18
BibTeX
@article{Bidder2015,
author = {Bidder, Therese M and Robinson, Douglas S},
title = {Asthma Exacerbations – The Focus For Treatment Of Severe Asthma?},
journal = {European Respiratory & Pulmonary Diseases},
year = {2015},
doi = {10.17925/erpd.2015.01.01.18}
}
EUVIMED